arrow_back Back to App

More Data on Addiction Treatment: New State Requirements

New regulations require states to collect and report detailed data on addiction treatment, including available medications and protocols to prevent misuse. This aims to improve program effectiveness and patient safety, potentially impacting the quality of healthcare for individuals struggling with addiction.
Key points
States must describe types of medication-assisted treatment drugs available.
Protocols for preventing diversion and misuse of these medications will be required.
States will need to collect data on misuse, including mixing with other prescription drugs.
Drug screening protocols for patients receiving medication-assisted treatment will be mandated.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_5630
Sponsor: Rep. Houchin, Erin [R-IN-9]
Process start date: 2025-09-30
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

To amend the Public Health Service Act to require additional information in State plans for Substance Use Prevention, Treatment, and Recovery Services block grants.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_5630.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-09-30.

What are the main provisions?

Key points include:

  • States must describe types of medication-assisted treatment drugs available.
  • Protocols for preventing diversion and misuse of these medications will be required.
  • States will need to collect data on misuse, including mixing with other prescription drugs.
  • Drug screening protocols for patients receiving medication-assisted treatment will be mandated.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Houchin, Erin [R-IN-9].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health